SPRO | NVO | VRTX | REGN | SGEN | MRNA | |
---|---|---|---|---|---|---|
Company Name | Spero Therapeutics, Inc. | Novo Nordisk A/S | Vertex Pharmaceuticals Incorporated | Regeneron Pharmaceuticals, Inc. | Seagen Inc. | Moderna, Inc. |
Sector | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare | Healthcare |
Industry | Biotechnology | Biotechnology | Biotechnology | Biotechnology | Biotechnology | Biotechnology |
Market Cap | $79.19M | $556.82B | $101.64B | $96.50B | $43.15B | $39.05B |
Employees | 0.05K | 63.37K | 5.40K | 13.45K | 3.26K | 5.60K |
CEO | Mr. Satyavrat Shukla C.F.A. | Mr. Lars Fruergaard Jorgensen | Dr. Reshma Kewalramani FASN, M.D. | Dr. Leonard S. Schleifer M.D., Ph.D. | Mr. David R. Epstein B.Sc., M.B.A. | Mr. Stephane Bancel |